State of 3D Printing, Bioprinting and Investment, Q4 2026 3D printing is a $24 billion industry growing about 11% a year, capital is flowing to fewer, larger production-scale bets in defense and metal, and bioprinting is still pre-commercial except for drug-testing tissue models. Market size: the real number is about $24 billion The most cited […]

Investing in Bioprinting: Startups, Stocks, and Tokens to Watch Including VC trends, public companies, and blockchain-based IP marketplaces Bioprinting—using additive manufacturing to print cells, tissues, and eventually organs—is moving from sci-fi to an investable frontier. Capital is flowing into next-gen tissue therapeutics, 3D cell-culture platforms for drug discovery, and enabling hardware/bioinks. At the same time, […]

MakerBot Stories | Feinstein Institute for Medical Research from MakerBot on Vimeo. Printing a trachea is much like printing any object, although it requires a bit more patience. MakerBot printers use a technique called extrusion printing, which creates objects out of successive thin layers of molten plastic that bind together as the printed object cools. […]